Blog

Vertex announces Casgevy reimbursement agreement for the treatment of sickle cell disease and transfusion-dependent beta thalassaemia in Germany

6 May 2026 - The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and ...